OUR LOCATION

322-Washington,America - 23

(+1)123 456 789

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Healthcare IT » HHE-4450117
  • Global Clinical Decision Support Systems Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: January 2017 | Report Code: HHE-4450117

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Clinical Decision support systems (CDSS) are fully computerized information systems which are designed to manage healthcare systems. The CDSS use patient’s information to provide evidence about them to health providers, which provide better summery reports. Global clinical decision support systems market is expected to have the CAGR of 12.2% during the forecast period 2016-2023. Due to the increasing number of chronic cases such as asthma and multiple sclerosis and diseases like cancer and diabetes, the global clinical decision support systems market is expected to grow. According to World Health Organization report, cancer cases are expected to reach up to 15 million by 2020. More than half of the deaths attributable to high blood glucose occur before the age of 70 years. As per WHO estimation diabetes will be the 7th leading cause of death by 2030. Such high number of cases would increase the demand of integrated form of healthcare provisions which are best managed by clinical decision support systems. CDSS leads to more safe, planned, efficient and effective medical decisions.

Global clinical decision support systems market is primarily driven by the following factors:

  • Increasing government support
  • High occurrence of chronic diseases
  • Increasing incidence of medication blunders
  • Increasing usage of big data and m-health tools
  • Increasing adoption of cloud computing in healthcare






The increasing popularity of clinical decision support systems (CDSS) in healthcare sector is the major factor driving the  global CDSS market with other factors such as high capital expenditure and maintenance requirement, privacy and security issues, and inadequate healthcare infrastructure. Chronic diseases such as chronic obstructive pulmonary disease (COPD), cardiovascular diseases, diabetes, and cancer with the rising effect of harmful use of alcohol, smoking, poor nutrition and physical inactivity is also increasing the demand for better medical decisions. Innovation and technological advancement helps in creating a higher productivity for businesses and helps them to launch varied  goods and services. It also enhances the internal part of production process at upward stage. Medical science has advanced exponentially during the last half of a decade. The paper system has hindered the capability to access the information vital to the delivery of care. On the basis of a survey, $600 billion is invested on lab tests each year in the U.S., out of that, 70 percent of the money pays for paperwork. Increasing service cost in healthcare industry has become a major challenge for every country, that’s why IT has now entered in the healthcare industry. IT provides quality based products and services to maintain all the information about patients and also reduces overall cost. The current condition of physical infrastructure of healthcare systems and their staff members reflects the requirements in infrastructure and services in the industry. Lack of adept IT professionals in the healthcare industry and rising complexity of the health sector and servicing organizations is a major challenge to be faced. Mainly, the problem arises in the underdeveloped general public health systems, inadequate medical training and service delivery.

 

Source: OBRC Analysis.

The global clinical decision support system market segments include type, product, model, user interactivity, application, component and delivery mode. Type is further segmented into:

  • Therapeutic clinical decision support systems,
  • Diagnostic clinical decision support systems



Product is further segmented into:

  • Standalone clinical decision support systems,
  • Integrated clinical decision support systems,



Model is further segmented into:

  • Knowledge-based clinical decision support systems,
  • Non-knowledge-based clinical decision support systems



User interactivity is further segmented into:

  • Passive clinical decision support systems
  • Active clinical decision support systems



Application is further segmented into:

  • Conventional clinical decision support systems,
  • Advanced clinical decision support systems



Component  is further segmented into:

  • Software
  • Hardware
  • Services




Delivery mode is further segmented into:

  • Cloud-based clinical decision support systems,
  • On premise clinical decision support systems
  • Web based clinical decision support system




The revenue for the above industrial verticals are specific to the clinical decision support system market. However, the total revenue of these application in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up type, product, model, user interactivity, and application, component and delivery mode segments.

Geographically, the global CDSS market is segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America is anticipated to account the largest market share and the fastest growth rate during the forecast period 2016-2023 due to the increasing cases of diseases, favorable policies framed by the government and the adoption of information technology. Asia pacific region is expected to show the highest growth rate due to the rising focus on improving healthcare infrastructure, rising adoption of advanced technologies and increasing government funds and initiatives to improve health care industry.

The global Clinic Decision Support System market is broadly segmented on the basis of component that is software, hardware and services. Delivery mode is further segmented into web-based clinical decision support systems, on- based clinical decision support systems; cloud- based clinical decision support systems. Product is further segmented into standalone clinical decision support systems, integrated clinical decision support systems.  Type is further segmented into  therapeutic clinical decision support systems, diagnostic clinical decision support systems. Model is further segmented into knowledge-based clinical decision support systems, non-knowledge-based clinical decision support systems; User interactivity is further segmented into passive clinical decision support systems, active clinical decision support systems. Application is further segmented into conventional clinical decision support systems, advanced clinical decision support systems, and geographically. In 2016, the software segment had the highest growth rate during the forecast period due to the need for periodic software upgradation. The market for cloud-based CDSS solutions is anticipated to register the highest growth rate in the upcoming period. Some additional functions such as assisting clinicians in real-time evidence based decision making, population health management, treatment planning, financial decision support, and protocol validation among others, advanced CDSS segment is projected to grow at the highest rate in the forecast period. Through built-in reference table, treatments, containing inbred information about different diseases, and other constraints which decreases clinical errors and aid in treatment planning, knowledge-based CDSS segment is expected to control the largest share of the global market and is projected to grow at the fastest rate in the forecast period.

The major market players of the global clinical decision support systems market are:

  • ALLSCRIPTS HEALTHCARE SOLUTIONS INC
  • CERNER CORPORATION
  • ZYNX HEALTH INCORPORATED
  • INTERNATIONAL BUSINESS MACHINE CORPORATION
  • SIEMENS AG
  • OTHERS







These companies use various strategies such as merger & acquisition, collaboration, partnership and product launching. Example: In April 2017 Siemens Healthineers are expanding its health management portfolio by acquiring Medicales which is a leading company in clinical decision support solutions. Through this acquisition the company will be benefited by medicalis expertise and going to provide clinical decision support system to health systems.Theacquisitionhelpsin optimizing utilization and departmental clinical workflow and thus extending the Siemens Healthineers strategy to give value based health care.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as product launch as in April 2017 the Siemens Healthineers is expanding its health management portfolio by acquiring Medicales of U.S.
  • Provide in detail the different segments such as products, type, component, application, delivery mode, user interactivity and model which affect the global clinical decision support system market.
  • Provide you the patent analysis of global clinical decision support system market.
  • Identify and understand the strengths, opportunities, challenges and threat of the clinical decision support system market.
  • Provide revenues of major players of the market such as General Electric Company, McKesson Corporation, and Wolters Kluwer
  • Provide you the various regulatory policies which affect the global clinical decision support system market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global decision support system market offers the longest chain of market segmentation covering major market segmentation based on products and end users. The report tracks the major market trends in the global smart security market such as development in video surveillance technology, content management, adoption of home cloud solutions and so on.  For each market segments covered in global smart security market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the smart security industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global smart security market:

  • North America had the largest revenue share in 2016.
  • Software segment is dominating the market due to the need for periodic software upgradation.
  • Acquisition is the key strategy adopted by the various market players of global CDDS market.
  • The market for cloud-based CDSS solutions is anticipated to register the highest growth rate in the upcoming period.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1.    INCREASING GOVERNMENT SUPPORT 
3.1.2.    INCREASING ADOPTION OF CLOUD COMPUTING IN HEALTHCARE 
3.1.3.    HIGH OCCURRENCE OF CHRONIC DISEASES
3.1.4. INCREASING INCIDENCE OF MEDICATION BLUNDERS
3.1.5.   INCREASING USAGE OF BIG DATA AND M-HEALTH TOOLS
3.2. MARKET RESTRAINTS
3.2.1. HUGE INVESTMENT IN IT INFRASTRUCTURE
3.2.2. DEFICIENCY OF SKILLED WORKFORCE
3.3. MARKET OPPORTUNITIES
3.3.1. EMERGING COUNTRIES FOR HEALTHCARE IT
3.3.2.   CDSS MARKET GROWTH ACROSS GLOBALLY
3.3.3. TECHNOLOGICAL ADVANCEMENT & INNOVATIONS
3.4.  MARKET CHALLENGES 
3.4.1. DEFICIENCY OF SKILLED IT PROFESSIONALS
 
4. MARKET SEGMENTATION 
4.1. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT 
4.1.3. DATABASE & ESTIMATION METHODOLOGY
4.1.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.5. OPPORTUNITY MATRIX
4.1.6. MARKET SEGMENTATION 
4.1.6.1. GLOBAL DIAGNOSTIC MARKET
4.1.6.1.1. APPLICATION
4.1.6.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.1.4. TOP PLAYERS & KEY PRODUCTS 
4.1.6.1.5. KEY CONCLUSIONS
4.1.6.2. GLOBAL THERAPEUTIC MARKET 
4.1.6.2.1. APPLICATION
4.1.6.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.2.4. TOP PLAYERS & KEY PRODUCTS 
4.1.6.2.5. KEY CONCLUSIONS
4.1.6.3. GLOBAL OTHERS MARKET
4.1.6.3.1. APPLICATION
4.1.6.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.6.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.6.3.4. TOP PLAYERS & KEY PRODUCTS 
4.1.6.3.5. KEY CONCLUSIONS
4.2. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY PRODUCT
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL STANDALONE MARKET 
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL INTEGRATED MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.2.5.2.5. KEY CONCLUSIONS
4.3. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY MODEL
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT 
4.3.3. DATABASE & ESTIMATION METHODOLOGY
4.3.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.5. OPPORTUNITY MATRIX
4.3.6. MARKET SEGMENTATION
4.3.6.1. GLOBAL KNOWLEDGE-BASED MARKET 
4.3.6.1.1. APPLICATION
4.3.6.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.6.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.6.1.4. TOP PLAYERS & KEY PRODUCTS 
4.3.6.1.5. KEY CONCLUSIONS
4.3.6.2. GLOBAL NON-KNOWLEDGE-BASED MARKET
4.3.6.2.1. APPLICATION
4.3.6.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.6.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.6.2.4. TOP PLAYERS & KEY PRODUCTS 
4.3.6.2.5. KEY CONCLUSIONS
4.4. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY USER INTERACTIVITY
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT 
4.4.3. DATABASE & ESTIMATION METHODOLOGY
4.4.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.5. OPPORTUNITY MATRIX
4.4.6. MARKET SEGMENTATION
4.4.6.1. GLOBAL ACTIVE MARKET
4.4.6.1.1. APPLICATION
4.4.6.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.6.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.6.1.4. TOP PLAYERS & KEY PRODUCTS 
4.4.6.1.5. KEY CONCLUSIONS
4.4.6.2. GLOBAL PASSIVE MARKET
4.4.6.2.1. APPLICATION
4.4.6.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.6.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.6.2.4. TOP PLAYERS & KEY PRODUCTS 
4.4.6.2.5. KEY CONCLUSIONS
4.5. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY APPLICATION
4.5.1. MARKET DEFINITION AND SCOPE
4.5.2. DECISION SUPPORT 
4.5.3. DATABASE & ESTIMATION METHODOLOGY
4.5.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.5.5. OPPORTUNITY MATRIX
4.5.6. MARKET SEGMENTATION
4.5.6.1. GLOBAL ADVANCED MARKET
4.5.6.1.1. APPLICATION
4.5.6.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.6.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.6.1.4. TOP PLAYERS & KEY PRODUCTS 
4.5.6.1.5. KEY CONCLUSIONS
4.5.6.2. GLOBAL CONVENTIONAL MARKET
4.5.6.2.1. APPLICATION
4.5.6.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.6.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.6.2.4. TOP PLAYERS & KEY PRODUCTS
4.5.6.2.5. KEY CONCLUSIONS
4.6. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY COMPONENET 
4.6.1. MARKET DEFINITION AND SCOPE
4.6.2. DECISION SUPPORT 
4.6.3. DATABASE & ESTIMATION METHODOLOGY
4.6.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.6.5. OPPORTUNITY MATRIX
4.6.6. MARKET SEGMENTATION
4.6.6.1. GLOBAL SOFTWARE MARKET
4.6.6.1.1. APPLICATION
4.6.6.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.6.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.6.6.1.4. TOP PLAYERS & KEY PRODUCTS
4.6.6.1.5. KEY CONCLUSIONS
4.6.6.2. GLOBAL SERVICES MARKET
4.6.6.2.1. APPLICATION
4.6.6.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.6.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.6.6.2.4. TOP PLAYERS & KEY PRODUCTS
4.6.6.2.5. KEY CONCLUSIONS
4.6.6.3. GLOBAL HARDWARE MARKET
4.6.6.3.1. APPLICATION
4.6.6.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.6.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.6.6.3.4. TOP PLAYERS & KEY PRODUCTS
4.6.6.3.5. KEY CONCLUSIONS
4.7. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY DELEVERY MODE 
4.7.1. MARKET DEFINITION AND SCOPE
4.7.2. DECISION SUPPORT 
4.7.3. DATABASE & ESTIMATION METHODOLOGY
4.7.4. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.7.5. OPPORTUNITY MATRIX
4.7.6. MARKET SEGMENTATION
4.7.6.1. GLOBAL CLOUD-BASED MARKET
4.7.6.1.1. APPLICATION
4.7.6.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.7.6.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.7.6.1.4. TOP PLAYERS & KEY PRODUCTS
4.7.6.1.5. KEY CONCLUSIONS
4.7.6.2. GLOBAL ON-PREMISE MARKET 
4.7.6.2.1. APPLICATION
4.7.6.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.7.6.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.7.6.2.4. TOP PLAYERS & KEY PRODUCTS
4.7.6.2.5. KEY CONCLUSIONS
4.7.6.3. GLOBAL WEB-BASED MARKET
4.7.6.3.1. APPLICATION
4.7.6.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.7.6.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.7.6.3.4. TOP PLAYERS & KEY PRODUCTS
4.7.6.3.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS &ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY REGION 
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES 
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. CERNER CORPORATION
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES 
7.2.5. SCOT ANALYSIS 
7.2.6. STRATEGIC ANALYSIS
7.3. ELSEVIER B.V. (A DIVISION OF THE RELX GROUP)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES 
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. EPIC SYSTEMS CORPORATION
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES 
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. GENERAL ELECTRIC COMPANY
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES 
7.5.5. SCOT ANALYSIS 
7.5.6. STRATEGIC ANALYSIS
7.6. IBM CORPORATION
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES 
7.6.5. SCOT ANALYSIS 
7.6.6. STRATEGIC ANALYSIS
7.7. INTERNATIONAL BUSINESS MACHINE (IBM) CORPORATION
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES 
7.7.5. SCOT ANALYSIS 
7.7.6. STRATEGIC ANALYSIS
7.8.  MCKESSON CORPORATION
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES 
7.8.5. SCOT ANALYSIS 
7.8.6. STRATEGIC ANALYSIS
7.9. MEDITECH
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES 
7.9.5. SCOT ANALYSIS 
7.9.6. STRATEGIC ANALYSIS
7.10. PHILIPS HEALTHCARE
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES 
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11.   RELX GROUP PLC
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES 
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. SIEMENS AG
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES 
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. THERMO SCIENTIFIC
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES 
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. WOLTERS KLUWER HEALTH
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES 
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. ZYNX HEALTH
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES 
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY TYPE 2014-2023 ($ MILLION)
2. GLOBAL DIAGNOSTIC MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL THERAPEUTIC MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY PRODUCT  2014-2023 ($ MILLION)
5. GLOBAL STANDALONE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
6. GLOBAL INTEGRATED MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY MODEL  2014-2023 ($ MILLION)
8. GLOBAL KNOWLEDGE-BASED MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL NON-KNOWLEDGE-BASED MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY USER INTERACTIVITY  2014-2023 ($ MILLION)
11. GLOBAL ACTIVE MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL PASSIVE MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET  BY APPLICATION 2014-2023 ($ MILLION)
14. GLOBAL ADVANCED MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL CONVENTIONAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS BY  COMPONENT 2014-2023 ($ MILLION)
17. GLOBAL SOFTWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
18. GLOBAL HARDWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
19. GLOBAL SERVICES  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
20. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS BY DELIVERY MODE  2014-2023 ($ MILLION)
21. GLOBAL CLOUD-BASED MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
22. GLOBAL ON-PREMISE MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
23. GLOBAL WEB-BASED MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
24. NORTH AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
25. EUROPE CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
26. ASIA PACIFIC CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
27. REST OF THE WORLD CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
 
 
LIST OF FIGURES
 
1. GLOBAL DIAGNOSTIC MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
2. GLOBAL THERAPEUTIC MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL STANDALONE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL INTEGRATED MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL KNOWLEDGE-BASED MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
6. GLOBAL NON-KNOWLEDGE-BASED MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL ACTIVE MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL PASSIVE MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL ADVANCED MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL CONVENTIONAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL SOFTWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL HARDWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL SERVICES  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL CLOUD-BASED MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL ON-PREMISE MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
16. GLOBAL WEB-BASED MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
17. UNITED STATES (U.S.) CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
18. CANADA CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
19. UNITED KINGDOM (UK) CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
20. FRANCE CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
21. GERMANY CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
22. SPAIN CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
23. ROE CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
24. INDIA CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
25. CHINA CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
26. JAPAN CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
27. AUSTRALIACLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
28. ROAPAC CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
29. LATIN AMERICA CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
30. MENA CLINICAL DECISION SUPPORT SYSTEMS MARKET  2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.